Delivery, safety and efficacy of 5-aminosalicylate preparations-Reference-Cited by-同舟云学术

Delivery, safety and efficacy of 5-aminosalicylate preparations

Published:1993-09 Issue:3 Volume:2 Page:277-287
ISSN:0925-4692
Container-title:Inflammopharmacology
language:en
Short-container-title:Inflammopharmacology

Author:

Bjarnason I.,Macpherson A. J.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/BF02660618.pdf

Reference93 articles.

1. Truelove SC. The evolution of the new salicylates. In: Goebell H, Peskar BM, Malchow H, eds. Inflammatory Bowel Disease - Basic Research and Clinical Implications. Falk Symposium 46. Lancaster: MTP Press Limited; 1988:333–7.

2. Svartz N. Salazopyrin, a new sulphonamide preparation. Acta Med Scand. 1942;110:577–98.

3. Svartz N. The primary cause of rheumatoid arthritis is an infection. The infectious agent exists in milk. Acta Med Scand. 1972;192:231–9.

4. Peppercorn MA, Goldman P. Distribution of salicylozosulfapyridine and its metabolites. Gastroenterology. 1973;64:240–5.

5. van Hogezand RA, van Hees PAM, van Gorp JPWM et al. Double-blind comparison of 5-amino salicylic acid and acetyl-5-amino salicylic acid suppositories in patients with idiopathic proctitis. Aliment Pharmacol Ther. 1988;2:33–40.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments;Nutrients;2023-02-18

2. Resveratrol and resveratrol nano-delivery systems in the treatment of inflammatory bowel disease;The Journal of Nutritional Biochemistry;2022-11

3. Critical Review of the Evidence on 5-Aminosalicilate for Chemoprevention of Colorectal Cancer in Ulcerative Colitis: A Methodological Question;Current Clinical Pharmacology;2014-02

4. Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats;Therapeutic Advances in Gastroenterology;2010-07-21

5. Pneumopathie interstitielle induite par la mésalazine;Gastroentérologie Clinique et Biologique;2010-03